Product Overview: Biogenic pharma Ligandrol Biogenic pharma
Ligandrol (LGD-4033) is a non-steroidal selective androgen receptor modulator characterised by high binding affinity and tissue selectivity in laboratory investigations. This research compound from Biogenic Pharma exhibits selective androgen receptor agonism, with preclinical data demonstrating anabolic activity in muscle and bone tissues while showing reduced androgenic effects on prostate tissue in animal models. Researchers investigating androgenic signalling pathways at Stroid UK Shop frequently examine LGD-4033 for its distinctive molecular properties and selectivity profile.
Laboratory Applications
Academic institutions examine Ligandrol for its mechanisms of action in androgen receptor research, particularly investigating tissue-specific responses and receptor binding kinetics. The compound has advanced through Phase I clinical trials, providing researchers with published data on pharmacokinetics and safety profiles for reference. Scientists studying muscle wasting conditions and osteoporosis models utilise this SARM to analyse selective androgenic pathways. Research teams examining Ligandrol compounds investigate its oral bioavailability and metabolic stability compared to other selective modulators available in the SARMs category. Comparative studies with peptide research compounds evaluate different mechanisms of tissue-selective activity.
Technical Specifications
| Property | Value |
|---|---|
| CAS Number | 1165910-22-4 |
| Molecular Formula | C₁₄H₁₂F₆N₂O |
| Molecular Weight | 338.25 g/mol |
| Classification | Non-steroidal SARM |
| Storage Conditions | Room temperature, protected from moisture |
| Research Applications | Androgen receptor studies, tissue selectivity research |
Research Compliance Information
This Ligandrol research compound is manufactured by Biogenic Pharma exclusively for laboratory research purposes and in-vitro scientific investigations. Not approved for human consumption, therapeutic use, or clinical applications. Researchers must maintain appropriate laboratory protocols and safety procedures when handling this selective androgen receptor modulator for experimental studies.
